Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 3, 2002, Pages 672-679

  Raherison, S ^a   Gonzalez, P ^a   Renaudin, H ^a   Charron, A ^a   Bebear C ^a   Bebear C M ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIFLAVINE; ADENOSINE TRIPHOSPHATE; ARGININE; CIPROFLOXACIN; DNA; ETHIDIUM BROMIDE; MOXIFLOXACIN; NORFLOXACIN; ORTHOVANADIC ACID; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RESERPINE;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DIFFUSION; DNA SEQUENCE; DRUG ACCUMULATION; DRUG UPTAKE; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA HOMINIS; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0036167744     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.3.672-679.2002     Document Type: Article

References (54)

1. Two highly similar multidrug transporters of Bacillus subtilis whose expression is differentially regulated
2. Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis
3. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides
4. Accumulation and killing kinetics of fifteen quinolones for Escherichia Staphylococcus aureus and Pseudomonas aeruginosa
5. Apparent involvement of a multidrug transporter in the fluoroquinolone resistance of Streptococcus pneumoniae
6. Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: Contributions of type II topoisomerase mutations and efflux to levels of resistance
7. Relationships among antibacterial activity, inhibition of DNA gyrase, and intracellular accumulation of 11 fluoroquinolones
8. Determination of minimal inhibitory concentration
9. Alterations in topoisomerase IV and DNA gyrase in quinolone-resistant mutants of Mycoplasma hominis obtained in vitro
10. Mutations in the gvrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis
11. Proton motive force-driven and ATP-dependent drug extrusion systems in multidrug-resistant Lactococcus lactis
12. Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae
13. Mechanisms of quinolone resistance in clinical isolates: Accumulation of sparfloxacin and of fluoroquinolones of various hydrophobicity, and analysis of membrane composition
14. mmr, a Mycobacterium tuberculosis gene conferring resistance to small cationic dyes and inhibitors
15. The accumulation of five quinolone antibacterial agents by Escherichia coli
16. Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci
17. The minimal gene complement of Mycoplasma genitalium
18. Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureus
19. Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae
20. Biochemistry of multidrug resistance mediated by the multidrug transporter
21. Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae
22. Bacterial topoisomerases, anti-topoisomerases, and antitopoisomerase resistance
23. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus
24. Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus
25. Introduction of a norA promoter region mutation into the chromosome of a fluoroquinolone-susceptible strain of Staphylococcus aureus using plasmid integration
26. Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus
27. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus
28. Mechanisms of fluoroquinolone resistance in Staphylococcus aureus
29. Role of efflux pumps(s) in intrinsic resistance of Pseudomonas aeniginosa: Resistance to tetracycline, chloramphenicol, and norfloxacin
30. Inhibition of the emergence of ciprofloxacin resistance in Streptococcus pneumoniae by the multidrug efflux inhibitor reserpine
31. Quinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus
32. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei
33. A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus
34. Efflux pump-mediated quinolone resistance in Staphylococcus aureus strains wild type for gvrA, gyrB, grL4, and norA
35. The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein
36. Efflux-mediated multidrug resistance in Bacillus subtilis: Similarities and dissimilarities with the mammalian system
37. Penetration of lipophilic agents with multiple protonation sites into bacterial cells: Tetracyclines and fluoroquinolones as examples
38. Microbial genome analyses: Global comparisons of transport capabilities based on phylogenies, bioenergetics and substrate specificities
39. Mdt(A), a new efflux protein conferring multiple antibiotic resistance in Lactococcus lactis and Escherichia coli
40. Antimicrobial activity and accumulation of moxifloxacin in quinolone-susceptible bacteria
41. Effect of hydrophobicity and molecular mass on the accumulation of fluoroquinolones by Staphylococcus aureus
42. Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli
43. Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium
44. Carbohydrate metabolism and energy conservation
45. Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria
46. Efflux-mediated resistance to fluoroquinolones in grampositive bacteria and the mycobacteria
47. Molecular properties of bacterial multidrug transporters
48. Accumulation of norfloxacin by Bacteroides fragilis
49. AcrD of Escherichia coli is an aminoglycoside efflux pump
50. Physicochemical properties of the fluoroquinolone antimicrobials. III. 1-Octanol/water partition coefficients and their relationships to structure
51. Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus
52. Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1
53. Bacterial evolution
54. Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae